Voices
Estela Rodriguez: ASCO Living Guideline Update in Stage IV NSCLC Without Driver Alterations
Estela Rodriguez/doctors.umiamihealth.org

Estela Rodriguez: ASCO Living Guideline Update in Stage IV NSCLC Without Driver Alterations

Estela Rodriguez, Associate Director of Community Outreach in Thoracic Oncology at the University of Miami’s Sylvester Comprehensive Cancer Center, shared a post on X:

”Off the press ASCO Living Guideline update:

Stage IV NSCLC without driver alterations 2026.3.1

Latest update incorporating new evidence for ICI-based regimens in stage IV NSCLC
Updates on: retifanlimab
Ivonescimab, plus BAP BRAIN (avastin+pemetrexed for Mets)”

Title: Therapy for Stage IV Non–Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, 2026.3.1

Authors: Lyudmila Bazhenova, Nofisat Ismaila, Greg Durm, Janet Freeman-Daily, Hidehito Horinouchi, Gary R. MacVicar, Deebya Raj Mishra, Bruna Pellini, Erin L. Schenk, Navneet Singh, Natasha B. Leighl

Read The Full Article on Journal of Clincal Oncology.

Estela Rodriguez: ASCO Living Guideline Update in Stage IV NSCLC Without Driver Alterations

Other Articles Featuring Estela Rodriguez on OncoDaily.

ASCO Bruna Pellini cancer Deebya Raj Mishra Erin L. Schenk Estela Rodriguez Gary R. MacVicar Greg Durm Hidehito Horinouchi Janet Freeman-Daily Lyudmila Bazhenova Natasha B. Leighl Natasha Leighl Navneet Singh Nofisat Ismaila NSCLC OncoDaily Oncology